| Application no. and date | 14726410.5 (espacenet) (Federated) (European Patent Register), 20140312 | | Patent/reg. no. and date | DK/EP 2968155, 20210303 | | Publication date | 20160120 | | Priority no. and date | US 201361802479 P, 20130316, US 201361864059 P, 20130809, US 201461934428 P, 20140131 | | EP pub. no. and date |
EP 2968155 20160120 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | V52094DK00 | | Inventor | Herbig, Scott Max, 39 Heritage Road
East Lyme,
Connecticut 06333, US,
KRISHNASWAMI, Sriram, 29 Plum Hill Road
East Lyme, Connecticut 06333, US,
KUSHNER IV, Joseph, 29 Beechwood Hollow
Bradford, Rhode Island 02808, US,
LAMBA, Manisha, 8 Giovanni Drive
Waterford, Connecticut 06385, US,
STOCK, Thomas C., 1703 Chantilly Lane
Chester Springs, Pennsylvania 19425, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 9/28 (2006.01) , A61K 9/48 (2006.01) , A61P 1/04 (2006.01) , A61P 17/06 (2006.01) , A61P 19/02 (2006.01) , A61P 37/06 (2006.01) | | Title | Orale tofacitinib-doseringsformer med langvarig frigivelse | | Int. application no. | IB2014059689 | | Int. publication no. | WO2014147526 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
